UNSPSC 51273916: Benzocaine/isopropyl alcohol/menthol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273916 Benzocaine/isopropyl alcohol/menthol is a Commodity code that in practice captures state and local procurement of pharmaceutical products, over-the-counter remedies, and related health commodities for public health and wellness programs. Recent solicitations under this code show state and local buyers acquiring naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and OTC products through cooperative purchasing networks, and direct-to-manufacturer prescription programs to optimize pharmacy benefit delivery and cost control. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances administering on behalf of multiple state and local participants (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other member jurisdictions). These buyers are pursuing both transactional purchases of specific health commodities and strategic market-intelligence initiatives to reshape their procurement relationships with manufacturers and wholesalers.

Geographic activity centers on Florida, Texas, and Minnesota with cooperative purchasing extending across multiple states and regions. Representative recent opportunities include Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, response due April 3, 2026) exploring direct-to-manufacturer prescription contracting capabilities outside traditional pharmacy benefit manager and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers, with contract performance commencing July 1, 2026. Vendors responding to these solicitations must meet federal compliance standards including FDA requirements, Drug Supply Chain Security Act certification, cGMP compliance, E-Verify eligibility confirmation, and in cooperative purchasing contexts, specified insurance thresholds and administrative fee structures.